Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 209

1.

Metabotropic glutamate receptor-1 as a novel target for the antiangiogenic treatment of breast cancer.

Speyer CL, Hachem AH, Assi AA, Johnson JS, DeVries JA, Gorski DH.

PLoS One. 2014 Mar 14;9(3):e88830. doi: 10.1371/journal.pone.0088830. eCollection 2014.

PMID:
24633367
[PubMed - in process]
Free PMC Article
2.

Lipid rafts serve as signaling platforms for mGlu1 receptor-mediated calcium signaling in association with caveolin.

Roh SE, Hong YH, Jang DC, Kim J, Kim SJ.

Mol Brain. 2014 Feb 10;7:9. doi: 10.1186/1756-6606-7-9.

PMID:
24512690
[PubMed - in process]
Free PMC Article
3.

Mining rare associations between biological ontologies.

Benites F, Simon S, Sapozhnikova E.

PLoS One. 2014 Jan 3;9(1):e84475. doi: 10.1371/journal.pone.0084475. eCollection 2014.

PMID:
24404165
[PubMed - in process]
Free PMC Article
4.

Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.

Domin H, Gołembiowska K, Jantas D, Kamińska K, Zięba B, Smiałowska M.

Neurotox Res. 2014 Jul;26(1):99-113. doi: 10.1007/s12640-013-9455-7. Epub 2014 Jan 9.

PMID:
24402869
[PubMed - in process]
Free PMC Article
5.

In vivo astrocytic Ca2+ signaling in health and brain disorders.

Ding S.

Future Neurol. 2013 Sep 1;8(5). pii: DOI 10.2217/fnl.13.38.

PMID:
24376372
[PubMed]
Free PMC Article
6.

Glutamate, glutamate receptors, and downstream signaling pathways.

Willard SS, Koochekpour S.

Int J Biol Sci. 2013 Sep 22;9(9):948-59. doi: 10.7150/ijbs.6426. eCollection 2013.

PMID:
24155668
[PubMed - in process]
Free PMC Article
7.

Presynaptic long-term plasticity.

Yang Y, Calakos N.

Front Synaptic Neurosci. 2013 Oct 17;5:8. doi: 10.3389/fnsyn.2013.00008. Review.

PMID:
24146648
[PubMed]
Free PMC Article
8.

Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.

Willard SS, Koochekpour S.

Int J Biol Sci. 2013 Aug 9;9(7):728-42. doi: 10.7150/ijbs.6475. eCollection 2013. Review.

PMID:
23983606
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Inhibition of the group I mGluRs reduces acute brain damage and improves long-term histological outcomes after photothrombosis-induced ischaemia.

Li H, Zhang N, Sun G, Ding S.

ASN Neuro. 2013 Jul 11;5(3):195-207. doi: 10.1042/AN20130002.

PMID:
23772679
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease.

Dickerson JW, Conn PJ.

Neurodegener Dis Manag. 2012 Apr 1;2(2):221-232.

PMID:
23526920
[PubMed]
Free PMC Article
11.

Two newly identified exons in human GRM1 express a novel splice variant of metabotropic glutamate 1 receptor.

DiRaddo JO, Pshenichkin S, Gelb T, Wroblewski JT.

Gene. 2013 May 1;519(2):367-73. doi: 10.1016/j.gene.2013.02.009. Epub 2013 Feb 24.

PMID:
23481697
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling.

Wierońska JM, Acher FC, Sławińska A, Gruca P, Lasoń-Tyburkiewicz M, Papp M, Pilc A.

Psychopharmacology (Berl). 2013 Jun;227(4):711-25. doi: 10.1007/s00213-013-3005-0. Epub 2013 Mar 10.

PMID:
23474845
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Metabotropic glutamate receptor 6 signaling enhances TRPM1 calcium channel function and increases melanin content in human melanocytes.

Devi S, Markandeya Y, Maddodi N, Dhingra A, Vardi N, Balijepalli RC, Setaluri V.

Pigment Cell Melanoma Res. 2013 May;26(3):348-56. doi: 10.1111/pcmr.12083. Epub 2013 Mar 27.

PMID:
23452348
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Metabotropic glutamate receptors drive global persistent inhibition in the visual thalamus.

Pressler RT, Regehr WG.

J Neurosci. 2013 Feb 6;33(6):2494-506. doi: 10.1523/JNEUROSCI.3458-12.2013.

PMID:
23392677
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample.

Park S, Jung SW, Kim BN, Cho SC, Shin MS, Kim JW, Yoo HJ, Cho DY, Chung US, Son JW, Kim HW.

Behav Brain Funct. 2013 Jan 7;9:1. doi: 10.1186/1744-9081-9-1.

PMID:
23295062
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Quantitative interactions between the A-type K+ current and inositol trisphosphate receptors regulate intraneuronal Ca2+ waves and synaptic plasticity.

Ashhad S, Narayanan R.

J Physiol. 2013 Apr 1;591(Pt 7):1645-69. doi: 10.1113/jphysiol.2012.245688. Epub 2013 Jan 2.

PMID:
23283761
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Synthesis, radiolabelling and in vitro and in vivo evaluation of a novel fluorinated ABP688 derivative for the PET imaging of metabotropic glutamate receptor subtype 5.

Sephton SM, Dennler P, Leutwiler DS, Mu L, Wanger-Baumann CA, Schibli R, Krämer SD, Ametamey SM.

Am J Nucl Med Mol Imaging. 2012;2(1):14-28. Epub 2011 Dec 10.

PMID:
23133799
[PubMed]
Free PMC Article
18.

Predictions not commands: active inference in the motor system.

Adams RA, Shipp S, Friston KJ.

Brain Struct Funct. 2013 May;218(3):611-43. doi: 10.1007/s00429-012-0475-5. Epub 2012 Nov 6. Review.

PMID:
23129312
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

mGluR-Dependent Synaptic Plasticity in Drug-Seeking.

Bellone C, Mameli M.

Front Pharmacol. 2012 Aug 27;3:159. doi: 10.3389/fphar.2012.00159. eCollection 2012.

PMID:
22969723
[PubMed]
Free PMC Article
20.

Therapeutic potential of metabotropic glutamate receptor modulators.

Hovelsø N, Sotty F, Montezinho LP, Pinheiro PS, Herrik KF, Mørk A.

Curr Neuropharmacol. 2012 Mar;10(1):12-48. doi: 10.2174/157015912799362805.

PMID:
22942876
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk